Allergic rhinitis affects 20 to 30% of adults in both the United States and Europe and perhaps
a somewhat higher percentage of children. In addition to nasal and ocular symptoms directly …

Allergen-specific immunotherapy (AIT) is currently recognized as a clinically effective
treatment for allergic diseases, with a unique disease-modifying effect. AIT was introduced in …

Allergen Immunotherapy (AIT) was introduced in clinical practice on an empirical basis more
than 100 years ago. Since the first attempts, AIT was administered subcutaneously. Indeed …

The years 1988-1995 witnessed the beginning of allergen cloning and the generation of
recombinant allergens, which opened up new avenues for the diagnosis and research of …

IgE‐associated allergic diseases belong to the most common inflammatory conditions. Their
clinical manifestation ranges from mild symptoms to life‐threatening episodes. Often patients …

Allergic rhinitis is a common condition, with significant impact on quality of life depending on
severity and quality of control. Allergen-specific immunotherapy (allergen-SIT) is the only …

The aim of the present study was to determine the pattern of symptoms of ragweed pollen-
induced allergic disease in sensitized patients from Romania and to compare the molecular …

Background: The dawn of the “omics” technologies has changed allergy research,
increasing the knowledge and identification of new allergens. However, these studies have …

Objective: to analyze component resolved diagnosis to Dermatophagoides pteronyssinus
(Der p) in patients with respiratory allergy and its relationship with clinical severity in different …

Asthma is frequently associated with atopy, characterized by the production of specific
immunoglobulin E in response to environmental allergens. Currently, two types of allergen …